Higher Preimplantation Opioid Doses Associated With Long‐Term Spinal Cord Stimulation Failure in 211 Patients With Failed Back Surgery Syndrome
Autor: | Henna-Kaisa Jyrkkänen, Mikael von und zu Fraunberg, Tiina-Mari Ikäheimo, Ville Leinonen, Jukka Huttunen, Mette Nissen |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Optimal cutoff
Spinal cord stimulation Time 03 medical and health sciences 0302 clinical medicine Clinical Research Dose escalation medicine Effective treatment Humans Failed Back Surgery Syndrome Spinal Cord Stimulation integumentary system business.industry opioids General Medicine Analgesics Opioid Anesthesiology and Pain Medicine Treatment Outcome Neurology Opioid nervous system Spinal Cord Anesthesia Cohort Morphine Neurology (clinical) business tissues 030217 neurology & neurosurgery medicine.drug Failed back surgery |
Zdroj: | Neuromodulation |
ISSN: | 1525-1403 1094-7159 |
Popis: | Objective Spinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two‐year follow‐up period. Materials and methods The study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two‐year follow‐up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries. Results Higher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p |
Databáze: | OpenAIRE |
Externí odkaz: |